NYSE US 100
18.004,88
PKT
-5,09
PKT
-0,03
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NYSE US 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 07.04.11 | Pfizer overweight | Barclays Capital | |
| 07.04.11 | Texas Instruments overweight | JP Morgan Chase & Co. | |
| 07.04.11 | Citigroup outperform | Sanford C. Bernstein and Co., Inc. | |
| 07.04.11 | Bristol-Myers Squibb overweight | Barclays Capital | |
| 06.04.11 | Procter Gamble outperform | Credit Suisse Group | |
| 06.04.11 | Bayer buy | UniCredit Research | |
| 06.04.11 | Bayer buy | UBS AG | |
| 06.04.11 | Texas Instruments reduce | Nomura | |
| 06.04.11 | Las Vegas Sands outperform | Credit Suisse Group | |
| 06.04.11 | Texas Instruments outperform | Credit Suisse Group | |
| 06.04.11 | Texas Instruments buy | Needham & Company, LLC | |
| 06.04.11 | Texas Instruments buy | Citigroup Corp. | |
| 05.04.11 | Bayer buy | Citigroup Corp. | |
| 05.04.11 | Texas Instruments buy | Kaufman Bros., LP | |
| 05.04.11 | Texas Instruments neutral | UBS AG | |
| 05.04.11 | Pfizer halten | Independent Research GmbH | |
| 05.04.11 | Walmart overweight | Barclays Capital | |
| 05.04.11 | Medtronic overweight | Barclays Capital | |
| 04.04.11 | Verizon outperform | RBC Capital Markets | |
| 04.04.11 | Goldman Sachs outperform | Credit Suisse Group | |
| 01.04.11 | Las Vegas Sands buy | Stifel, Nicolaus & Co., Inc. | |
| 01.04.11 | Walmart overweight | Barclays Capital | |
| 01.04.11 | American International Group (AIG) neutral | UBS AG | |
| 01.04.11 | Procter Gamble buy | Goldman Sachs Group Inc. | |
| 01.04.11 | Bayer buy | UBS AG | |
| 01.04.11 | Bayer outperform | Credit Suisse Group | |
| 31.03.11 | Bristol-Myers Squibb hold | Jefferies & Company Inc. | |
| 31.03.11 | UnitedHealth perform | Oppenheimer & Co. Inc. | |
| 30.03.11 | Halliburton buy | Société Générale Group S.A. (SG) | |
| 30.03.11 | Bayer buy | UniCredit Research | |
| 30.03.11 | Bayer overweight | J.P. Morgan Cazenove | |
| 30.03.11 | Schlumberger buy | Société Générale Group S.A. (SG) | |
| 30.03.11 | General Dynamics buy | Jefferies & Company Inc. | |
| 29.03.11 | Bristol-Myers Squibb overweight | Barclays Capital | |
| 29.03.11 | Honeywell overweight | Morgan Stanley | |
| 29.03.11 | Bristol-Myers Squibb buy | Goldman Sachs Group Inc. | |
| 29.03.11 | Verizon outperform | RBC Capital Markets | |
| 28.03.11 | AT&T outperform | Robert W. Baird & Co. Incorporated | |
| 28.03.11 | Verizon outperform | Robert W. Baird & Co. Incorporated | |
| 28.03.11 | Bayer neutral | Credit Suisse Group |